Domestic companies challenging Vesicare’s substance patent

On the 9^th, Astellas Korea announced it filed a patent infringement prohibition suit over Vesicare jointly with its headquarters against CorePharm Bio to the Seoul Central District Court

Since no foreign pharmaceutical company has revealed the fact of filing a patent infringement suit to the press, the move of Astellas is considered as unprecedented.

In particular, the CorePharm Bio’s follo...